Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Evolva: Swiss Watchmaker

The chemistry bottleneck in drug discovery is defined by the time and cost required to identify and synthesize new compounds. Evolva Ltd. says its Watchmaker yeast-based technology helps it discover compounds faster than traditional high throughput screening and medicinal chemistry methods. The company adds that it also can create compounds that are hard to make using other techniques.

Watchmaker introduces hundreds of genes into

Read the full 641 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers